Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.
about
The Cryptococcus neoformans capsule: a sword and a shield.Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation.The CSF Immune Response in HIV-1-Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral TherapyThe capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibodyEarly induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans.Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the hostEvidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.The role of host gender in the pathogenesis of Cryptococcus neoformans infections.Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans.Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis.Immune correlates of HIV-associated cryptococcal meningitisRole of the mannose receptor in a murine model of Cryptococcus neoformans infectionA Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis.Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.Glycoconjugates and polysaccharides of fungal cell wall and activation of immune systemThe capsule of the fungal pathogen Cryptococcus neoformans.A critical role for FcgammaRIIB in up-regulation of Fas ligand induced by a microbial polysaccharide.The environmental yeast Cryptococcus liquefaciens produces capsular and secreted polysaccharides with similar pathogenic properties to those of C. neoformans.Rim Pathway-Mediated Alterations in the Fungal Cell Wall Influence Immune Recognition and Inflammation.Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells.Regulated release of cryptococcal polysaccharide drives virulence and suppresses immune infiltration into the central nervous system.Cryptococcus neoformans infective endocarditis of native valves in an immunocompetent host.Variability in innate host immune responses to cryptococcosis.Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection
P2860
Q24619875-04FBAAA8-32AF-440D-859C-0824508A74A3Q33675737-00907849-B219-4EBE-B06B-12C1B4484A72Q33793447-F3BCD561-34B6-41E5-A4C5-EBC78B9CB2AFQ34001769-CCD67A3C-B07D-452E-9072-4B2FFBA1ED67Q34003199-C64B32D9-D1E9-4558-AD1A-E55C96093FD9Q34007117-A23F787C-CC24-4968-A605-24E0A6151D5DQ34055174-0086B6BA-ED03-498E-B639-A1DFD602203FQ34561087-B34082D9-C56F-4B2D-BFA2-391DA4EBE1C7Q34760386-8AA27094-24C6-4EA1-8AFE-40D9B12118D1Q35122257-77A3E5D7-AD21-42CF-95A2-B70FFCD5850FQ35641032-DC593F55-3820-4019-BDF0-23C69EF157E4Q36250573-7CED01A4-7133-44EC-A0D9-CCA5754FFD6FQ36320051-38FADF09-F5AD-4EBC-B8F0-6EF7170D7202Q36710580-C58BC532-2A27-4A4B-AA8D-433FEC79441CQ36871924-4F15B847-F819-46F9-9A64-7C7E6CFCE279Q37115803-6A7B8048-9C23-4C63-AEB0-204BFBF1882EQ37159154-233B581B-085D-4BFB-B02C-9B7C71BAB8FBQ37337879-588B798F-17D6-4CDD-8317-A1303635804CQ39538013-3147CB9C-748D-498D-BFCE-10D6D7ACBA2FQ40238846-80168832-9218-43C3-AED7-11D3EEAB42E5Q40351228-E0B3A6C8-2BCD-4DC8-BB62-46DBBBB002D5Q44016595-9152C911-4A8E-4D91-B7B2-78850164C6D0Q47370987-985AE31D-ACAF-4369-ABCB-D23165E509D5Q55262558-275C30CA-EFAF-48FF-AC4B-EB70DD44FB5EQ55400028-53469271-A5DE-420D-8F0A-AEE20A762882Q58608737-85821929-B48D-4F81-A840-9DC7A2DA8A6D
P2860
Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Encapsulation of Cryptococcus ...... senting capacity of monocytes.
@en
Encapsulation of Cryptococcus ...... senting capacity of monocytes.
@nl
type
label
Encapsulation of Cryptococcus ...... senting capacity of monocytes.
@en
Encapsulation of Cryptococcus ...... senting capacity of monocytes.
@nl
prefLabel
Encapsulation of Cryptococcus ...... senting capacity of monocytes.
@en
Encapsulation of Cryptococcus ...... senting capacity of monocytes.
@nl
P2093
P2860
P1476
Encapsulation of Cryptococcus ...... senting capacity of monocytes.
@en
P2093
P2860
P304
P407
P577
1998-02-01T00:00:00Z